Search clinical trials for: Ursodeoxycholic Acid

Total 23809 results

HighTide Biopharma Pty Ltd

Withdrawn

A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)

Adolescent | Digestive System Diseases | Biliary Tract Diseases | Primary Sclerosing Cholangitis | Cholangitis | Cholangitis, Sclerosing | Bile Duct Diseases
Ewha Womans University

Unknown

Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis

End-Stage Kidney Disease
Hvidovre University Hospital
University of Copenhagen

Completed

Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass

Severe Obesity

Denmark
Ethan Weinberg
American Association for the Study of Liver Diseases; Meridian Bioscience,...

Terminated

Ursodeoxycholic Acid (UDCA) for Hepatic Sarcoidosis

Hepatic Sarcoidosis, Elevated Alkaline Phosphatase

United States
NYU Langone Health

Completed

C. Difficile and Ursodiol

Diarrhea

United States
University of Bologna

Withdrawn

Ursodeoxycholic Acid And Cholestasis Of Pregnancy (CERTO)

Intrahepatic Cholestasis of Pregnancy

Italy
National Heart and Lung Institute
Dr. Falk Pharma GmbH

Unknown

Ursodeoxycholic Acid in Chronic Heart Failure

Heart Failure, Congestive

United Kingdom
Alexandra Hospital, Athens, Greece

Recruiting

Genetic Polymorphisms of ABCB11 and ABCB4 in Women With Intrahepatic Cholestasis of Pregnancy (ICP) and in Their First Degree Relatives

Cholestasis of Pregnancy

Greece
Seoul National University Hospital

Unknown

Clinical Trial to Investigate Pharmacokinetics, Metabolomics and Biomarker in Elderly After UDCA Administration

Aged

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction

Fatigue

Korea, Republic of
Radboud University Medical Center
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Completed

Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease (CURSOR)

Polycystic Kidney, Autosomal Dominant | Polycystic Liver Disease

Netherlands, Spain
Medical Centre Hospital of the President's Affairs...
Eurasia Invest Ltd.; Ministry of Education and Science, Republic of Kazakhstan

Completed

Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis

Non-alcoholic Steatohepatitis

Kazakhstan
National Scientific Medical Center, Kazakhstan
Eurasia Invest Ltd.; Ministry of Education and Science, Republic of Kazakhstan

Completed

Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis

Primary Biliary Cirrhosis

Kazakhstan
University Clinical Centre of Kosova
University of Zagreb

Unknown

The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice

Obstructive Jaundice

Serbia
US Department of Veterans Affairs

Completed

Clinical Studies on Bile Acids in Barrett's Esophagus

Gastroesophageal Reflux Disease

United States
Xinhua Hospital, Shanghai Jiao Tong University...

Unknown

MITE in the Treatment of Dyspepsia After Cholecystectomy

Patients With Dyspeptic Symptoms After Cholecystectomy
Hopital Foch

Not yet recruiting

Ursodeoxycholic Acid (UDCA) as a Neuroprotective Adjuvant Treatment to Rhegmatogenous Retinal Detachment Surgery (UDCA)

Retinal Detachment

France
National Institute of Diabetes and Digestive and...

Terminated

Trial of High-dose Urso in Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis

United States
Mirum Pharmaceuticals, Inc.

Completed

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis (CLARITY)

Primary Biliary Cirrhosis | PBC

United States, United Kingdom, Canada
Daewoong Pharmaceutical Co. LTD.

Completed

Comparative Bioavailability Study of UDCA

Healthy
National Center for Research Resources (NCRR)
Children's Hospital Medical Center, Cincinnati

Unknown

Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease

Gastrointestinal Diseases | Cystic Fibrosis | Cholestasis

United States
Hospital General Universitario de Alicante
Instituto de Salud Carlos III

Not yet recruiting

Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis (OSOPOLAR)

Acute Pancreatitis Due to Gallstones

Spain
Xiaoli Fan

Recruiting

Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

Cholangitis | Hepatitis, Autoimmune | Cholestasis | Liver Cirrhosis, Biliary

China
Teva Pharmaceuticals USA

Completed

Ursodiol 500 mg Tablets Under Fed Conditions

Healthy

Canada
Shandong Linglong Yingcheng Hospital

Recruiting

Probiotics for Gallstones in Post-bariatric Surgery Patients

Probiotics | Bariatric Surgery Candidate | Gallstone | Gastrointestinal Quality of Life Index | Gallstone Attack

China
HighTide Biopharma Pty Ltd

Recruiting

Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes

T2DM (Type 2 Diabetes Mellitus)

China
Taipei Veterans General Hospital, Taiwan

Unknown

Cholestatic Drug-induced Liver Injury (DILI)

Hepatitis, Toxic

Taiwan
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET (ReLUTH)

Progressive Disease | Neuroendocrine Tumors | Intestinal Well Differentiated Endocrine Tumor

France
Tanta University

Completed

Evaluating the Effect of Digoxin and Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Egypt
Children's Hospital Medical Center, Cincinnati

Completed

Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis

Cystic Fibrosis

United States, Italy
Daewoong Pharmaceutical Co. LTD.

Completed

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions

Healthy

Canada
Medstone International

Terminated

Lithotripsy for the Treatment of Gallstones

Cholelithiasis

United States
Daewoong Pharmaceutical Co. LTD.

Completed

A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions

Healthy

Canada
West China Hospital

Unknown

A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis

Primary Biliary Cholangitis

China
National Cancer Institute (NCI)

Completed

Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

Barrett Esophagus | Esophageal Carcinoma

United States
Teva Pharmaceuticals USA

Completed

Ursodiol Tablets 500 mg Under Fasting Conditions

Healthy

Canada
HighTide Biopharma Pty Ltd

Recruiting

Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Type 2 Diabetes Mellitus

China
National Institute of Diabetes and Digestive and...

Completed

Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)

Healthy Volunteers

United States
American University of Beirut Medical Center
Makassed General Hospital

Unknown

Effectiveness of Ursodeoxycholic Acid Use in the Prevention of Gallstone Formation After Sleeve Gastrectomy

Cholelithiasis

Lebanon
National Taiwan University Hospital
PharmaEssentia

Not yet recruiting

A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection

Hepatitis D

Taiwan
King's College London
Guy's and St Thomas' NHS Foundation Trust

Recruiting

Ursodeoxycholic Acid vs Metformin in Gestational Diabetes Mellitus (GUARD)

Gestational Diabetes

United Kingdom
Vanderbilt University Medical Center

Terminated

Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans

Glucose Intolerance | Gastric Bypass Surgery

United States
West China Hospital

Recruiting

Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II

Hepatitis, Autoimmune | Primary Biliary Cholangitis

China
China National Center for Cardiovascular Diseases

Active, not recruiting

Prophylactic Effect of Nirmatrelvir/Ritonavir and Ursodeoxycholic Acid on Reducing Complications After Cardiac Surgery (PEP)

Cardiac Surgery

China
Radboud University Medical Center
Dutch Cancer Society

Completed

Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis (PreDuoFAP)

Familial Adenomatous Polyposis | Duodenal Neoplasms | Duodenal Polyps

Netherlands
Children's Hospital Medical Center, Cincinnati
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Intralumenal Effects on Cholesterol Absorption/Synthesis

Healthy

United States
Daewoong Pharmaceutical Co. LTD.

Recruiting

To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy

Gastric Cancer

Korea, Republic of
The University of Texas Health Science Center at...

Withdrawn

Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants

Liver Disease | Cholestasis

United States
Kanazawa University

Unknown

Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases

Type 2 Diabetes Mellitus | Chronic Liver Disease

Japan
Kafrelsheikh University

Completed

Comparing the Effects of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Non-alcoholic Steatohepatitis (NASH) Patients

Nonalcoholic Steatohepatitis (NASH)

Egypt

Search clinical trials for: Ursodeoxycholic Acid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations